Subscribe to the newsletter

[x]

Stay in touch with the scientific world!

Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

Anna Ohlden

Media Relations Executive, PR Newswire Europe... Read More »

Northrop Grumman Introduces New Widescreen Technology For Ship Navigation Systems

Sep 23 2008 | comment(s)

LONDON, September 23 /PRNewswire/ --

At the 2008 SMM maritime technology exhibition this month, Northrop Grumman Corporation's (NYSE: NOC) Sperry Marine business unit will unveil the newest enhancement to its VisionMaster FT(TM) lineup of marine navigation systems -- a widescreen high-resolution display with 25 percent more viewing area.

A photo accompanying this release is available at: http://media.primezone.com/noc/

CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit

Sep 23 2008 | comment(s)

BAGNOLS-SUR-CÈZE, France, September 23 /PRNewswire/ --

- Company's Expertise in Chromogranin A Tumor Detection Marker Technology Now Applied to Universal Technique

CISBIO Bioassays, a member of IBA group and a developer and marketer of diagnostic assays for the quantification of tumor markers, announced today the launch of its chromogranin A ELISA diagnostic tool, Chromoa. This ELISA kit complements CISBIO's existing chromogranin A RIACT kit and can be used by all laboratories for the detection and monitoring of neuroendocrine tumors.

Sarantel Offers Real LBS Potential To Handset Manufacturers With New Antenna Launch

Sep 23 2008 | comment(s)

LONDON, September 23 /PRNewswire/ --

- Proven to Significantly Outperform Existing GPS Antennas

- Patented Technology Enabling Hands-Free Pedestrian Navigation

- Proven to Reduce Drain on Battery Life by More Than 10 Percent

- Small Enough to Fit in the Slimmest and Most Compact Handset Models

- Samples Available on https://samples.sarantel.com

LONDON, September 23 /PRNewswire/ --

Recruitment Completed In Ofatumumab NHL Pivotal Study

Sep 23 2008 | comment(s)

COPENHAGEN, September 23 /PRNewswire/ --

- Summary: Genmab has Completed Recruitment of Patients in the Phase III Study of Ofatumumab in Rituximab Refractory Follicular NHL.

Alcatel-Lucent And Deutsche Telekom Launch Web User Interface For Smart Metering Trial In "T-City" Friedrichshafen

Sep 23 2008 | comment(s)

AMSTERDAM - Metering, Billing/CRM Europe 2008, September 23 /PRNewswire/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) and Deutsche Telekom today announced that they launch a web-based Smart Metering user interface for the E-Metering field trial, which is running in the German city of Friedrichshafen.